{"count": 3, "results": [{"_id": "37354673", "pmid": 37354673, "title": "METFORMIN EFFECTS ON BLOOD LEVELS OF GREMLIN-1 IN POLYCYSTIC OVARIAN WOMEN.", "journal": "Georgian Med News", "authors": ["Allow S", "Sarhat E"], "date": "2023-04-01T00:00:00Z", "meta_date_publication": "2023 Apr", "meta_volume": "", "meta_issue": "337", "meta_pages": "51-55", "score": 50280.2, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@METFORMIN@@@ EFFECTS ON BLOOD LEVELS OF @<m>DISEASE_Renal_cell_carcinoma_1</m> @DISEASE_MESH:C538557 @@@GREMLIN-1@@@ IN POLYCYSTIC OVARIAN @SPECIES_9606 @@@WOMEN@@@.", "citations": {"NLM": "Allow S, Sarhat E. METFORMIN EFFECTS ON BLOOD LEVELS OF GREMLIN-1 IN POLYCYSTIC OVARIAN WOMEN. Georgian Med News. 2023 Apr;(337):51-55. PMID: 37354673", "BibTeX": "@article{37354673, title={METFORMIN EFFECTS ON BLOOD LEVELS OF GREMLIN-1 IN POLYCYSTIC OVARIAN WOMEN.}, author={Allow S and Sarhat E}, journal={Georgian Med News}, number={337}, pages={51-55}}"}}, {"_id": "37354674", "pmid": 37354674, "title": "METFORMIN EFFECTS ON NEUREGULIN-1 IN POLYCYSTIC OVARIAN WOMEN.", "journal": "Georgian Med News", "authors": ["Tawfeq M", "Sarhat E"], "date": "2023-04-01T00:00:00Z", "meta_date_publication": "2023 Apr", "meta_volume": "", "meta_issue": "337", "meta_pages": "56-62", "score": 50280.2, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@METFORMIN@@@ @DISEASE_Metabolic_Side_Effects_of_Drugs_and_Substances @DISEASE_MESH:D065606 @@@EFFECTS@@@ ON @<m>DISEASE_Renal_cell_carcinoma_1</m> @DISEASE_MESH:C538557 @@@NEUREGULIN-1@@@ IN POLYCYSTIC OVARIAN @SPECIES_9606 @@@WOMEN@@@.", "citations": {"NLM": "Tawfeq M, Sarhat E. METFORMIN EFFECTS ON NEUREGULIN-1 IN POLYCYSTIC OVARIAN WOMEN. Georgian Med News. 2023 Apr;(337):56-62. PMID: 37354674", "BibTeX": "@article{37354674, title={METFORMIN EFFECTS ON NEUREGULIN-1 IN POLYCYSTIC OVARIAN WOMEN.}, author={Tawfeq M and Sarhat E}, journal={Georgian Med News}, number={337}, pages={56-62}}"}}, {"_id": "16391903", "pmid": 16391903, "title": "The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).", "journal": "Diabetologia", "authors": ["Ramachandran A", "Snehalatha C", "Mary S", "Mukesh B", "Bhaskar AD", "Vijay V", "Indian Diabetes Prevention Programme (IDPP)"], "date": "2006-02-01T00:00:00Z", "doi": "10.1007/s00125-005-0097-z", "meta_date_publication": "2006 Feb", "meta_volume": "49", "meta_issue": "2", "meta_pages": "289-97", "score": 50060.594, "text_hl": "The Indian @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Prevention Programme shows that lifestyle modification and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prevent @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ in Asian Indian subjects with @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ (@<m>DISEASE_Renal_cell_carcinoma_1</m> @DISEASE_MESH:C538557 @@@IDPP-1@@@).", "citations": {"NLM": "Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006 Feb;49(2):289-97. PMID: 16391903", "BibTeX": "@article{16391903, title={The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).}, author={Ramachandran A and Snehalatha C and Mary S and Mukesh B and Bhaskar AD and Vijay V and Indian Diabetes Prevention Programme (IDPP)}, journal={Diabetologia}, volume={49}, number={2}, pages={289-97}}"}}]}